SPX Gestao de Recursos Ltda Buys Shares of 109,330 Hyperliquid Strategies Inc $PURR

SPX Gestao de Recursos Ltda bought a new position in shares of Hyperliquid Strategies Inc (NASDAQ:PURR) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 109,330 shares of the company’s stock, valued at approximately $860,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. State of Wyoming purchased a new position in shares of Hyperliquid Strategies in the 2nd quarter valued at about $46,000. Shepherd Financial Partners LLC acquired a new stake in shares of Hyperliquid Strategies in the second quarter valued at about $79,000. Boothbay Fund Management LLC purchased a new stake in Hyperliquid Strategies during the fourth quarter worth about $40,000. Lotus Technology Management LP purchased a new stake in Hyperliquid Strategies during the second quarter worth about $93,000. Finally, XTX Topco Ltd acquired a new position in Hyperliquid Strategies during the fourth quarter worth about $48,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on PURR. Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 3rd. Cantor Fitzgerald set a $22.60 price target on Hyperliquid Strategies and gave the stock an “overweight” rating in a research note on Thursday. Finally, Chardan Capital boosted their price target on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research note on Friday. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.53.

Hyperliquid Strategies News Roundup

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Hyperliquid Strategies reported fiscal 2026 net income of approximately $305.5 million and highlighted major operational progress, including more than doubling its HYPE treasury, launching a large network validator and completing its exit from legacy biotech operations. Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
• Positive Sentiment: The company disclosed a HYPE position valued at roughly $1.9 billion, with its treasury reportedly reaching about 29.3 million tokens. Investors appear to be treating the treasury as a direct way to gain exposure to the Hyperliquid ecosystem. Hyperliquid Strategies Shares Rise After Reporting $1.9B HYPE Position
• Positive Sentiment: HYPE reached a record price near $84.80, increasing the reported value of Hyperliquid Strategies’ token holdings and supporting the stock’s momentum. Hyperliquid HYPE Surges to Record $84.80
• Neutral Sentiment: Chardan Capital reaffirmed a Buy rating and raised its outlook, but its reported $9.75 price target is below the stock’s recent trading level, suggesting analysts may be lagging the rally or see limited near-term upside. Why Is Hyperliquid Strategies Stock Up on Friday?
• Negative Sentiment: Technical commentary warns that the HYPE rally may be becoming stretched, while the company’s results and valuation remain highly sensitive to cryptocurrency prices. A reversal in HYPE could reduce the value of PURR’s treasury and pressure the shares. Hyperliquid Price Forecast

Hyperliquid Strategies Stock Performance

Hyperliquid Strategies stock opened at $11.61 on Friday. Hyperliquid Strategies Inc has a fifty-two week low of $3.01 and a fifty-two week high of $14.14. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of -1.58 and a beta of 1.71. The stock’s fifty day moving average is $7.86 and its two-hundred day moving average is $6.88.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.